BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2468596)

  • 1. Immunoreactive cytokeratins in plasmacytomas.
    Wotherspoon AC; Norton AJ; Isaacson PG
    Histopathology; 1989 Feb; 14(2):141-50. PubMed ID: 2468596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular and epididymal plasmacytoma: a report of 7 cases, including three that were the initial manifestation of plasma cell myeloma.
    Ferry JA; Young RH; Scully RE
    Am J Surg Pathol; 1997 May; 21(5):590-8. PubMed ID: 9158685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratins in plasmacytomas.
    Battifora H
    Histopathology; 1989 Sep; 15(3):321-2. PubMed ID: 2478440
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokeratins in plasmacytomas.
    Haboubi NY; Clark P
    Histopathology; 1990 Nov; 17(5):482. PubMed ID: 1706301
    [No Abstract]   [Full Text] [Related]  

  • 6. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells.
    Govender D; Harilal P; Dada M; Chetty R
    J Clin Pathol; 1997 Jun; 50(6):490-3. PubMed ID: 9378815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and differential diagnoses of solitary extramedullary plasmacytoma of the thyroid: a case report.
    Avila A; Villalpando A; Montoya G; Luna MA
    Ann Diagn Pathol; 2009 Apr; 13(2):119-23. PubMed ID: 19302961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
    Vasef MA; Medeiros LJ; Yospur LS; Sun NC; McCourty A; Brynes RK
    Mod Pathol; 1997 Sep; 10(9):927-32. PubMed ID: 9310957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERG expression in multiple myeloma-A potential diagnostic pitfall.
    Knief J; Reddemann K; Gliemroth J; Brede S; Bartscht T; Thorns C
    Pathol Res Pract; 2017 Feb; 213(2):130-132. PubMed ID: 27913051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma.
    Strickler JG; Audeh MW; Copenhaver CM; Warnke RA
    Cancer; 1988 May; 61(9):1782-6. PubMed ID: 3355976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoma of the pancreas: an unusual manifestation of multiple myeloma.
    Hue SS; Azhar R
    Singapore Med J; 2013 May; 54(5):e105-7. PubMed ID: 23716161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
    Zukerberg LR; Yang WI; Arnold A; Harris NL
    Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Solitary plasmacytoma: a clinicopathologic and immunophenotypic analysis of 43 cases].
    Yang F; Liu WP; Jiang LL; Li FY; Liao DY; Li GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):93-6, 144. PubMed ID: 16468652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Solitary plasmacytoma of spine: a clinical, radiologic and pathologic study of 13 cases].
    He MX; Zhu MH; Zhang YM; Fu QG; Wu LL
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):307-11. PubMed ID: 19575872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
    Ramos-Vara JA; Miller MA; Valli VE
    Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins.
    Norton AJ; Thomas JA; Isaacson PG
    Histopathology; 1987 May; 11(5):487-99. PubMed ID: 2440791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary lymph node plasmacytomas (plasmacytic lymphomas).
    Menke DM; Horny HP; Griesser H; Tiemann M; Katzmann JA; Kaiserling E; Parwaresch R; Kyle RA
    Am J Clin Pathol; 2001 Jan; 115(1):119-26. PubMed ID: 11190797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.
    Poston RN; Sidhu YS
    J Clin Pathol; 1986 May; 39(5):514-23. PubMed ID: 2424934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based clonality analysis of antigen receptor gene rearrangements in canine cutaneous plasmacytoma.
    Takanosu M; Okada K; Kagawa Y
    Vet J; 2018 Nov; 241():31-37. PubMed ID: 30340657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.